Home Newsfeeds Benchmark Downgrades Emergent BioSolutions to Hold

Benchmark Downgrades Emergent BioSolutions to Hold

Benchmark analyst Robert Wasserman downgrades Emergent BioSolutions (NYSE:EBS) from Buy to Hold.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Benchmark analyst Robert Wasserman downgrades Emergent BioSolutions (NYSE:EBS) from Buy to Hold.

Sumo Logic Names Joe Kim As President And Chief Executive Officer Succeeding Ramin Sayar, Effective Immediately

By Happy Mohamed

May 15, 9:32 AM

Sumo Logic, the SaaS analytics platform to enable reliable and secure cloud-native applications, today announced that Joe Kim has been appointed President and Chief Executive Officer, effective immediately. Mr. Kim

SUMO

News
Tech

Elon Musk Says The New Version Of Gemini Will Still Be The Same But Make Its ‘Politically Correct’ Responses More Subtle And Less Obvious

By Ananya Gairola

April 9, 4:47 AM

Elon Musk discussed the need for AI regulation and criticized Alphabet Inc.'s Google's Gemini AI for its "politically correct" programming, which he considers dangerous, during a live discussion with Nicolai Tangen.

GOOG